SCHEMBL3016957

SCHEMBL3016957

COc1ccc(OC)c(Cc2csc(N3CCC(S(=O)(=O)c4cccc(Br)c4)CC3)n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.37
MAPT P10636 6/20 0.37
LMNA P02545 3/20 0.37
RECQL P46063 2/20 0.37
EGFR P00533 2/20 0.37
TSHR P16473 2/20 0.37
POLB P06746 1/20 0.37
ADRB2 P07550 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
GPR6 P46095 2/20 0.36
HSD17B10 Q99714 3/20 0.36
USP2 O75604 1/20 0.36
GHSR Q92847 1/20 0.35
PDGFRB P09619 2/20 0.35
FLT1 P17948 1/20 0.35
KDR P35968 1/20 0.35
REV1 Q9UBZ9 1/20 0.35
HTT P42858 1/20 0.35
FKBP1A P62942 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3018532 0.93 MAPT (0.36) TP53MAPTLMNARECQLTSHR
SCHEMBL2999879 0.91 PSMD14 (0.37) MAPTRECQLPOLBGPR6HSD17B10
SCHEMBL3007192 0.91 SMN1; SMN2 (0.38) TP53MAPTLMNARECQLTSHR
SCHEMBL3019030 0.90 KDM1A (0.39) TP53MAPTLMNARECQLTSHR
SCHEMBL3012854 0.90 THRB (0.41) TP53MAPTLMNARECQLTSHR
SCHEMBL3017438 0.89 KDM4E (0.43) TP53MAPTLMNARECQLTSHR
SCHEMBL3008649 0.88 ALDH1A1 (0.38) TP53MAPTLMNARECQLTSHR
SCHEMBL3014895 0.88 MAPT (0.39) TP53MAPTLMNARECQLTSHR
SCHEMBL2999753 0.88 MAPT (0.45) MAPTLMNARECQLTSHRSMN1; SMN2
SCHEMBL3001526 0.87 GPR6 (0.41) TP53MAPTLMNARECQLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA TP53 2880/4885MAPT 18/4885LMNA 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.